Skip to content
★ Sign in to follow
SB

Steven B. Miller

Executive
Total declarations
62
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (5 ops.)
€5.4M

Latest filing published 06 Nov 2025 for BrightSpring Health Services, Inc., €128k.

Filing timeline

BuySale
Steven B. Miller

Insider track record

Disclosed buys
0
Disclosed sells
5
Signal history

Steven B. Miller: trading record in brief

Steven B. Miller discloses dealings in 3 companies, chiefly Express Scripts Holding Co., Cigna Corp and BrightSpring Health Services, Inc. In total, 62 filings cover trades dated from 28 February 2014 to 5 November 2025.

Sales make up the whole of the open-market record (5 sales, €5.4M). Other entries cover 48 share grants and 7 option exercises.

Most recently, on 6 November 2025, the filings show a share grant worth €128k in BrightSpring Health Services, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Steven B. Miller

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations62 total
  • ◆
    DirectorExecutivesBrightSpring Health Services, Inc.
    146,962 USD19SEC
    4,497 shares@ US$32.68100.0% of flowCommon StockSEC:0000908834-25-000319:0
  • ◆
    DirectorExecutivesBrightSpring Health Services, Inc.
    0SEC
    11,912 shares0Common StockSEC:0000908834-25-000144:0
  • ◆
    DirectorExecutivesBrightSpring Health Services, Inc.
    0SEC
    10,708 shares0Common StockSEC:0000908834-24-000302:0
  • ◆
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    80,549 USD11SEC
    383 shares@ US$210.310.7% of flowCommon Stock, $.01 Par ValueSEC:0001225208-21-004366:1
  • ◆
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    176,316 USD11SEC
    840 shares@ US$209.901.6% of flowCommon Stock, $.01 Par ValueSEC:0001225208-21-004366:2
  • ◆
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    360,682 USD11SEC
    1,715 shares@ US$210.313.2% of flowCommon Stock, $.01 Par ValueSEC:0001225208-21-004366:3
  • ◆
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    0SEC
    3,831 shares0Common Stock, $.01 Par ValueSEC:0001225208-21-004366:0
  • ◆
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    0SEC
    1,287 shares0Common Stock, $.01 Par ValueSEC:0001225208-21-003975:0
  • ◆
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    130,950 USD11SEC
    622 shares@ US$210.531.2% of flowCommon Stock, $.01 Par ValueSEC:0001225208-21-001888:0
  • ◇
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    1M USD12SEC
    8,972 shares@ US$160.6612.5% of flowCommon Stock, $.01 Par ValueSEC:0001225208-21-000701:0
  • ▼
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    2M USD28SEC
    8,972 shares@ US$210.0016.4% of flowCommon Stock, $.01 Par ValueSEC:0001225208-21-000701:1
  • ◇
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    124,833 USD11SEC
    777 shares@ US$160.661.1% of flowCommon Stock, $.01 Par ValueSEC:0001225208-21-000701:2
  • ◆
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    27,678 USD11SEC
    149 shares@ US$185.760.9% of flowCommon Stock, $.01 Par ValueSEC:0001225208-20-003962:0
  • ◆
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    153,934 USD12SEC
    858 shares@ US$179.415.1% of flowCommon Stock, $.01 Par ValueSEC:0001225208-20-003962:2
  • ◆
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    260,872 USD12SEC
    1,426 shares@ US$182.948.7% of flowCommon Stock, $.01 Par ValueSEC:0001225208-20-003962:3
  • ◆
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    0SEC
    2,178 shares0Common Stock, $.01 Par ValueSEC:0001225208-20-003962:1
  • ◆
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    0SEC
    1,433 shares0Common Stock, $.01 Par ValueSEC:0001225208-20-003811:0
  • ◇
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    1M USD14SEC
    8,406 shares@ US$121.1434.2% of flowCommon Stock, $.01 Par ValueSEC:0001225208-20-002233:0
  • ▼
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    2M USD28SEC
    7,145 shares@ US$212.1551.0% of flowCommon Stock, $.01 Par ValueSEC:0001225208-20-002233:1
  • ◆
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    328,122 USD11SEC
    1,881 shares@ US$174.444.9% of flowCommon Stock, $.01 Par ValueSEC:0001225208-19-004413:0
  • ◆
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    0SEC
    1,500 shares0Common Stock, $.01 Par ValueSEC:0001225208-19-004249:1
  • ◇
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    1M USD13SEC
    12,566 shares@ US$110.4720.6% of flowCommon Stock, $.01 Par ValueSEC:0001225208-19-004249:0
  • ◇
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    123,285 USD11SEC
    1,116 shares@ US$110.471.8% of flowCommon Stock, $.01 Par ValueSEC:0001225208-19-004249:2
  • ◆
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    146,745 USD11SEC
    812 shares@ US$180.722.2% of flowCommon Stock, $.01 Par ValueSEC:0001225208-19-004249:3
  • ◆
    EVP, Chief Clinical OfficerExecutivesCigna Corp
    2M USD13SEC
    9,135 shares@ US$180.7224.5% of flowCommon Stock, $.01 Par ValueSEC:0001225208-19-004249:4

25 of 62 declarations